The DOI matches its Crossref record.
Out-of-Pocket Costs for Diabetes Medications in Employer-Sponsored Health Insurance Plans
Abstract
Out-of-pocket costs of diabetes medications other than insulin can be quite high for individuals with employer-sponsored health insurance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, lower-cost treatment alternatives, such as metformin or DPP-4 inhibitors, are available for patients with type 2 diabetes.28”
From Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity (2025) · cites this paper as [28]
Citations
Cited by
Sorted by citations
Rodriguez, P. J., Zhang, V., Gratzl, S., Do, D., Goodwin Cartwright, B., Baker, C., Gluckman, T. J., Stucky, N., & Emanuel, E. J. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.57349 · Cited by 374
Metadata
- Authors
- Quach, J.
- Corresponding author
- J Quach
- Venue
- The American Journal of Managed Care
- Published
- 2024-03-01
- Volume
- 30
- Issue
- 3
- Pages
- 107-108
- ISSN
- 1088-0224 (ISSN-L)
- 1936-2692
- OpenAlex
- W4392600236
- Cited by
- 7
- References
- 0
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 1
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Managed Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
- Keywords
- antidiabetic drugs, out-of-pocket costs, employer-sponsored health insurance, cost sharing, insulin, drug affordability, managed care
- MeSH terms
- Costs and Cost Analysis, Diabetes Mellitus, Health Expenditures, Health Benefit Plans, Employee, Humans, Insulin, Insurance, Health, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Out-of-Pocket Costs for Diabetes Medications in Employer-Sponsored Health Insurance Plans. https://app.cochat.ai/papers/10.37765/ajmc.2024.89510
- The paper
- Quach, J. (2024). Out-of-Pocket Costs for Diabetes Medications in Employer-Sponsored Health Insurance Plans. The American Journal of Managed Care. https://doi.org/10.37765/ajmc.2024.89510
